CKD (Chronic Kidney Disease) Management Panel in UAE | 600 AED | DNA Labs UAE

Executive Summary & Core Metrics

The CKD Management Panel delivers 99.9% diagnostic accuracy using the latest DHA-approved methodologies. DNA Labs UAE provides hospital-grade home sample collection via an ISO 9001:2015 certified cold-chain logistics network, VIP mobile phlebotomy, and post-test tele-clinical guidance for comprehensive result interpretation. Verify your insurance coverage by WhatsApp at +971 54 548 8731.

Test Overview & Methodology

The CKD Management Panel provides a precise, DHA-compliant assessment of kidney function using IDMS-traceable enzymatic creatinine, eGFR by CKD-EPI equation, and urine albumin-to-creatinine ratio (ACR) immunoturbidimetry. This advanced profile uncovers occult chronic kidney disease and accurately classifies its stages for early intervention.

Parameter	Our CKD Management Panel	Routine Renal Panel
Methodology	IDMS-traceable enzymatic creatinine, immunoturbidimetric ACR, indirect ISE, CLIA	Jaffé kinetic (non-IDMS), dipstick protein
Key Measurands	eGFR (CKD-EPI), cystatin C (optional), urine ACR	Serum creatinine, BUN; no ACR, no eGFR formula updates
Turnaround Time	Same-day reporting (within 24 h)	48–72 h
Regulatory Adherence	Full DHA & ISO 9001:2015	Minimal

Physician Insight & Safety Protocols

Dr. Ajay Singh (DHA License: 36234132), General Practitioner: “The CKD Management Panel is a cornerstone screening tool for early kidney impairment. Results must always be interpreted within the full clinical context – including blood pressure trends, medication history, and imaging findings. Never adjust diuretics or antihypertensives based solely on a single lab value. Collaborate with a kidney specialist to formulate a long-term renal preservation strategy.”

Medication Advisory & Safety Precautions

IMPORTANT: Do not discontinue prescribed medications, including ACE inhibitors, ARBs, diuretics, or immunosuppressants, without consulting your doctor. Abrupt cessation can precipitate acute kidney injury or hypertensive crisis. Contact your clinician immediately if you experience sudden swelling, breathlessness, or reduced urine output.

Exclusion Criteria & Emergency Red Flags

Exclusion for Home Collection: Active urinary tract infection, known contrast-induced nephropathy within 48 hours, haemolysed sample risk (difficult veins), acute decompensated heart failure.
Do Not Test If: Pregnant (physiological hyperfiltration alters reference ranges) – discuss with obstetrician first; children under 18 require parental consent per UAE Federal Laws.
Emergency Red Flags: Sudden anuria (<100 mL urine in 24 h), severe flank pain with fever (>38.5°C), acute muscle weakness or palpitations (possible hyperkalemia), new-onset confusion. Visit the ER immediately.

Patient FAQ & Clinical Guidance

1. What analytes are included in the CKD Management Panel, and why is it important?

The panel measures serum creatinine, eGFR, and urine albumin-to-creatinine ratio to detect chronic kidney disease early and guide treatment. This comprehensive profile aligns with DHA guidelines, enabling accurate staging (1–5) and monitoring of disease progression, thereby preventing end-stage renal disease.

2. How should I prepare for the CKD Management Panel?

You must fast for 8–10 hours and collect a first-morning urine sample between 8 and 10 AM for optimal accuracy. Inform the phlebotomist of any recent strenuous exercise or high-protein meal, as these can transiently elevate creatinine levels.

3. What if my results are abnormal – what are the next steps?

Abnormal results may indicate kidney dysfunction, requiring a nephrologist consultation to stage CKD and initiate renal-protective strategies. Do not panic; many factors are reversible. Our post-test clinical guidance can connect you with a DHA-licensed specialist within 24 hours.

UAE Regulatory & Data Privacy Adherence

DNA Labs UAE strictly complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical testing safety and patient consent protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. All laboratory operations maintain ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139).

Clinical & Logistical Metadata

Test Name	CKD (Chronic Kidney Disease) Management Panel
Price (AED)	600
Turnaround Time	Same-day reporting (within 24 hours)
Sample Type / Matrix	Peripheral whole blood (Serum), First-morning mid-stream urine
Methodology Used	IDMS-traceable enzymatic creatinine, eGFR (CKD-EPI), Immunoturbidimetric ACR
ICD-10-CM Code	N18.9
LOINC Code	33914-3, 3097-7, 14959-1, 30000-4
DHA Facility License & Address	DNA Labs UAE \| License No. 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE